In contrast, patients with Alzheimer’s disease (Angiolillo et al., 2021) and with Guillain-Barré syndrome (Pacheco et al., 2021) were reported to display lower activities of anti-Gal IgM and IgG isotypes than healthy individuals. This evidence concerns the gene GAL and early-onset autosomal dominant Alzheimer disease.